Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JAMF
3301
DELISTED
Jamf
JAMF
| $5.81M | ﹤0.01% |
194,132
+139,653
| +256% | +$4.61M |
|
|
MTACU
3302
DELISTED
MedTech Acquisition Corporation Unit
MTACU
| $5.8M | ﹤0.01% |
+552,789
| New | +$5.77M |
|
3303
OrthoPediatrics
KIDS
$648M
| $5.8M | ﹤0.01% |
140,561
+83,321
| +146% | +$3.82M |
|
|
CMD
3304
DELISTED
Cantel Medical Corporation
CMD
| $5.79M | ﹤0.01% |
73,450
-10,936
| -13% | -$641K |
|
3305
Medpace
MEDP
$16.1B
| $5.79M | ﹤0.01% |
41,586
+12,763
| +44% | +$1.61M |
|
|
SGMO
3306
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $5.79M | ﹤0.01% |
370,800
+153,400
| +71% | +$1.8M |
|
3307
CALL
KKR & Co
KKR
$102B
| $5.78M | ﹤0.01% |
142,800
-10,800
| -7% | -$408K |
|
3308
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.77B
| $5.78M | ﹤0.01% |
34,393
-374
| -1% | -$60.7K |
|
3309
VanEck Mortgage REIT Income ETF
MORT
$375M
| $5.78M | ﹤0.01% |
+344,897
| New | +$5.29M |
|
3310
PUT
CEL-SCI Corp
CVM
$26.9M
| $5.77M | ﹤0.01% |
16,507
+2,024
| +14% | +$798K |
|
3311
CALL
BlackBerry
BB
$5.22B
| $5.77M | ﹤0.01% |
870,800
+492,200
| +130% | +$2.91M |
|
|
GLUU
3312
DELISTED
Glu Mobile Inc.
GLUU
| $5.77M | ﹤0.01% |
640,695
+361,961
| +130% | +$3.12M |
|
3313
CALL
Fortive
FTV
$18.6B
| $5.77M | ﹤0.01% |
108,151
-19,027
| -15% | -$978K |
|
3314
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.32B
| $5.77M | ﹤0.01% |
52,954
-80,333
| -60% | -$8.56M |
|
|
ONT
3315
Onterris Inc
ONT
$619M
| $5.77M | ﹤0.01% |
186,277
+172,165
| +1,220% | +$4.89M |
|
3316
CALL
Snap-on
SNA
$20.9B
| $5.77M | ﹤0.01% |
33,700
+9,100
| +37% | +$1.52M |
|
3317
CALL
Motorola Solutions
MSI
$77.2B
| $5.76M | ﹤0.01% |
33,900
-39,800
| -54% | -$6.68M |
|
3318
CALL
Constellium
CSTM
$4.01B
| $5.76M | ﹤0.01% |
412,000
+253,400
| +160% | +$2.86M |
|
3319
WisdomTree International MidCap Dividend Fund
DIM
$169M
| $5.76M | ﹤0.01% |
90,639
+58,482
| +182% | +$3.49M |
|
3320
CALL
Aurinia Pharmaceuticals
AUPH
$2.06B
| $5.76M | ﹤0.01% |
416,600
+185,000
| +80% | +$2.69M |
|
|
LL
3321
PUT
DELISTED
LL Flooring Holdings, Inc.
LL
| $5.76M | ﹤0.01% |
187,400
-10,400
| -5% | -$289K |
|
3322
CALL
Omega Healthcare
OHI
$14.1B
| $5.76M | ﹤0.01% |
158,500
-23,300
| -13% | -$790K |
|
3323
John Hancock Multifactor Developed International ETF
JHMD
$987M
| $5.75M | ﹤0.01% |
185,032
+66,548
| +56% | +$1.94M |
|
|
AMRN
3324
PUT
Amarin Corp
AMRN
$297M
| $5.75M | ﹤0.01% |
58,835
-12,970
| -18% | -$1.25M |
|
3325
CALL
Copa Holdings
CPA
$6.14B
| $5.75M | ﹤0.01% |
74,500
+30,600
| +70% | +$2.04M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.